_version_ 1785090440646623232
author Annunziata, Mario
Lunghi, Monia
Giglio, Fabio
Leoncin, Matteo
Dargenio, Michelina
Bonifacio, Massimiliano
De Gobbi, Marco
Mazzone, Carla
Agrippino, Roberta
Lazzarotto, Davide
Roncoroni, Elisa
Defina, Marzia
Fracchiolla, Nicola
Guolo, Fabio
Ilaria Del Principe, Maria
Scappini, Barbara
Mulè, Antonino
Ciccone, Maria
Pasciolla, Crescenza
Ferrara, Felicetto
Pizzolo, Giovanni
Foà, Robin
Chiaretti, Sabina
author_facet Annunziata, Mario
Lunghi, Monia
Giglio, Fabio
Leoncin, Matteo
Dargenio, Michelina
Bonifacio, Massimiliano
De Gobbi, Marco
Mazzone, Carla
Agrippino, Roberta
Lazzarotto, Davide
Roncoroni, Elisa
Defina, Marzia
Fracchiolla, Nicola
Guolo, Fabio
Ilaria Del Principe, Maria
Scappini, Barbara
Mulè, Antonino
Ciccone, Maria
Pasciolla, Crescenza
Ferrara, Felicetto
Pizzolo, Giovanni
Foà, Robin
Chiaretti, Sabina
author_sort Annunziata, Mario
collection PubMed
description
format Online
Article
Text
id pubmed-10428323
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283232023-08-17 P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY Annunziata, Mario Lunghi, Monia Giglio, Fabio Leoncin, Matteo Dargenio, Michelina Bonifacio, Massimiliano De Gobbi, Marco Mazzone, Carla Agrippino, Roberta Lazzarotto, Davide Roncoroni, Elisa Defina, Marzia Fracchiolla, Nicola Guolo, Fabio Ilaria Del Principe, Maria Scappini, Barbara Mulè, Antonino Ciccone, Maria Pasciolla, Crescenza Ferrara, Felicetto Pizzolo, Giovanni Foà, Robin Chiaretti, Sabina Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428323/ http://dx.doi.org/10.1097/01.HS9.0000968400.53053.b9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Annunziata, Mario
Lunghi, Monia
Giglio, Fabio
Leoncin, Matteo
Dargenio, Michelina
Bonifacio, Massimiliano
De Gobbi, Marco
Mazzone, Carla
Agrippino, Roberta
Lazzarotto, Davide
Roncoroni, Elisa
Defina, Marzia
Fracchiolla, Nicola
Guolo, Fabio
Ilaria Del Principe, Maria
Scappini, Barbara
Mulè, Antonino
Ciccone, Maria
Pasciolla, Crescenza
Ferrara, Felicetto
Pizzolo, Giovanni
Foà, Robin
Chiaretti, Sabina
P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
title P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
title_full P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
title_fullStr P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
title_full_unstemmed P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
title_short P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
title_sort p372: cmv reactivations/infections in ph+ all patients treated with dasatinib with or without blinatumomab. a retrospective multicenter campus all study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428323/
http://dx.doi.org/10.1097/01.HS9.0000968400.53053.b9
work_keys_str_mv AT annunziatamario p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT lunghimonia p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT gigliofabio p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT leoncinmatteo p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT dargeniomichelina p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT bonifaciomassimiliano p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT degobbimarco p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT mazzonecarla p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT agrippinoroberta p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT lazzarottodavide p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT roncoronielisa p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT definamarzia p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT fracchiollanicola p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT guolofabio p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT ilariadelprincipemaria p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT scappinibarbara p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT muleantonino p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT cicconemaria p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT pasciollacrescenza p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT ferrarafelicetto p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT pizzologiovanni p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT foarobin p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy
AT chiarettisabina p372cmvreactivationsinfectionsinphallpatientstreatedwithdasatinibwithorwithoutblinatumomabaretrospectivemulticentercampusallstudy